| Financial Year |
March 31 2023 |
| Monetary Funds |
523,267,298.66 |
| Held-for-trading Financial Assets |
160,690,410.96 |
| Notes Receivable |
24,550,942.33 |
| Accounts Receivable |
182,578,179.72 |
| Advances to Suppliers |
48,994,721.42 |
| Other Receivables |
6,941,707.40 |
| Amounts Due From Related Companies |
-- |
| Interest Receivable |
-- |
| Dividend Receivable |
-- |
| Inventories |
190,112,084.82 |
| Among: Consumptive Biological Assets |
-- |
| Non-Current Assets Maturing Within One Year |
-- |
| Other Current Assets |
149,875,202.53 |
| Total Current Assets |
1,287,010,547.84 |
| Available-for-Sale Financial Asset |
-- |
| Held-to-maturity Investments |
-- |
| Long-Term Account Receivable |
-- |
| Long-term Equity Investment |
-- |
| Investment Properties |
-- |
| Fixed Assetes |
728,384,591.95 |
| Under-construction Projects |
152,116,294.16 |
| Construction Materials |
-- |
| Disposal of Fixed Assets |
-- |
| Capitalized Biological Assets |
-- |
| Oil and Gas Assets |
-- |
| Intangible Assets |
88,661,345.41 |
| R&D expenses |
-- |
| Goodwill |
-- |
| Long-Term Deferred and Prepaid Expenses |
176,244.91 |
| Deferred Income Tax Assets |
15,146,150.57 |
| Other Non-Current Assets |
612,248.27 |
| Sub-Total of Non-Current Assets |
1,024,262,851.45 |
| Total Assets |
2,311,273,399.29 |
| Short-Term Loans |
-- |
| Trading Financial liabilities |
-- |
| Notes Payable |
112,764,985.74 |
| Accounts Payable |
239,839,870.28 |
| Accounts Received In Advance |
2,173,622.80 |
| Employee Compensation Payable |
4,737,312.50 |
| Taxes Payable |
15,709,255.41 |
| Interest Payable |
-- |
| Dividend Payable |
-- |
| Other payables |
39,803,094.45 |
| Due to Related Companies |
-- |
| Non-Current Liabilities Due Within One Year |
-- |
| Other Current Liabilities |
-- |
| Sub-Total of Current Liabilities |
417,260,751.42 |
| Long-term Loans |
-- |
| Bonds Payable |
-- |
| Long-Term Accounts Payable |
-- |
| Special Payable |
-- |
| Estimatied Liabilities |
241,259.28 |
| Deferred Income Tax Liabilities |
45,993,080.64 |
| Other Non-Current Liabilities |
-- |
| Sub-Total of Non-Current Liabilities |
84,378,098.74 |
| Total Liabilities |
501,638,850.16 |
| Paid-In Capital(Or Share Stock) |
169,932,000.00 |
| Capital Surplus |
1,022,442,893.74 |
| Surplus Reserve |
59,329,685.31 |
| LESS:Treasury Stock |
-- |
| Undistributed Profits |
576,295,723.08 |
| Minority Stockholder's Interest |
20.52 |
| Foreign Currency Capital |
-- |
| Abnormal Management Project Income Adjusted |
-- |
| Total Owners' Equity Attributable to Parent(Stockholder's Interest) |
1,809,634,528.61 |
| Owner's Equity（Stockholder's Equity） |
1,809,634,549.13 |
| Total Liabilities and Owner's Equity（Stockholder's Equity） |
2,311,273,399.29 |
